PatchSiren

PatchSiren cyber security CVE debrief

CVE-2023-6519 Mia Technology Inc. CVE debrief

CVE-2023-6519 was published on 2024-02-08 and affects Mia-Med versions before 1.0.7. The issue is described as an exposure of data element to the wrong session that can allow sensitive strings within an executable to be read. NVD records a CVSS v3.1 score of 7.5 (High) with network attack vector, no privileges required, and no user interaction, indicating a serious confidentiality-focused exposure for affected deployments.

Vendor
Mia Technology Inc.
Product
MİA-MED
CVSS
HIGH 7.5
CISA KEV
Not listed in stored evidence
Original CVE published
2024-02-08
Original CVE updated
2026-05-20
Advisory published
2024-02-08
Advisory updated
2026-05-20

Who should care

Organizations running Mia-Med before 1.0.7, especially teams responsible for application security, patch management, and handling of sensitive data stored or embedded in the executable. Security responders should also care if the product is deployed in environments where unauthorized reading of embedded strings could expose credentials, endpoints, or other secrets.

Technical summary

NVD lists the vulnerability as an Exposure of Data Element to Wrong Session issue, with a secondary CWE-488 classification from the USOM advisory. The affected CPE is mia-teknoloji/mia-med versions earlier than 1.0.7. The recorded CVSS vector is CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N, which points to a remotely reachable confidentiality issue rather than an integrity or availability impact.

Defensive priority

High. Patch priority should be elevated for any environment that still runs Mia-Med before 1.0.7, because the issue is externally reachable in the CVSS assessment and can expose sensitive information without authentication or user interaction.

Recommended defensive actions

  • Upgrade Mia-Med to version 1.0.7 or later.
  • Inventory all deployments to confirm no affected versions remain in production, test, or packaged distributions.
  • Review whether the executable contains secrets, tokens, endpoints, or other sensitive strings that should be removed or protected.
  • Validate session isolation and access-control behavior in any workflows that handle sensitive data elements.
  • If exposure is suspected, rotate any credentials or secrets that may have been embedded in affected builds.
  • Monitor the vendor and USOM references for any additional remediation guidance or updated advisories.

Evidence notes

The debrief is based only on the supplied NVD record and the linked USOM references. Source data states the issue affects Mia-Med before 1.0.7 and describes it as an exposure of data element to wrong session leading to reading sensitive strings within an executable. NVD metadata also includes CVSS 3.1 vector AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N and a secondary CWE-488 mapping from the USOM advisory. No KEV listing was provided.

Official resources

Publicly disclosed on 2024-02-08. The supplied data does not indicate KEV inclusion or known ransomware campaign use.